Cargando…
Alzheimer’s Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound
Alzheimer’s disease (AD) is a progressive neurodegenerative disease with an insidious onset and multifactorial nature. A deficit in neurogenesis and synaptic plasticity are considered the early pathological features associated with neurofibrillary tau and amyloid β pathologies and neuroinflammation....
Autores principales: | Baazaoui, Narjes, Iqbal, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599095/ https://www.ncbi.nlm.nih.gov/pubmed/36291618 http://dx.doi.org/10.3390/biom12101409 |
Ejemplares similares
-
A Novel Therapeutic Approach to Treat Alzheimer’s Disease by Neurotrophic Support During the Period of Synaptic Compensation
por: Baazaoui, Narjes, et al.
Publicado: (2018) -
Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound
por: Baazaoui, Narjes, et al.
Publicado: (2017) -
Inhibition of AMD-Like Pathology With a Neurotrophic Compound in Aged Rats and 3xTg-AD Mice
por: Liu, Yinghua, et al.
Publicado: (2019) -
Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction
por: Wei, Wei, et al.
Publicado: (2021) -
Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease
por: Kazim, Syed Faraz, et al.
Publicado: (2016)